» Articles » PMID: 29229597

Nkx2-2as Suppression Contributes to the Pathogenesis of Sonic Hedgehog Medulloblastoma

Overview
Journal Cancer Res
Specialty Oncology
Date 2017 Dec 13
PMID 29229597
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Aberrant Hedgehog signaling and excessive activation of the Gli family of transcriptional activators are key drivers of medulloblastoma (MB), the most common human pediatric brain malignancy. MB originates mainly from cerebellar granule neuron progenitors (CGNP), but the mechanisms underlying CGNP transformation remain largely obscure. In this study, we found that suppression of the noncoding RNA Nkx2-2as promoted Sonic Hedgehog (Shh)-potentiated MB development. Nkx2-2as functioned as a competing endogenous RNA against miR-103 and miR-107, sequestering them and thereby derepressing their tumor suppressive targets BTG2 and LATS1 and impeding cell division and migration. We also found that Nkx2-2as tethered miR-548m and abrogated its LATS2 targeting activity. Shh signaling impaired Nkx2-2as expression by upregulating the transcriptional repressor FoxD1. In clinical specimens of Shh-subgroup MB, we validated coordinated expression of the aforementioned proteins. Notably, exogenous expression of Nkx2-2as suppressed tumorigenesis and prolonged animal survival in MB mouse models. Our findings illuminate the role of noncoding RNAs in Hedgehog signaling and MB occurrence, with implications for identifying candidate therapeutic targets for MB treatment. These findings illuminate the role of noncoding RNAs in Hedgehog signaling and an interplay between the Hedgehog and Hippo pathways in medulloblastoma pathogenesis. .

Citing Articles

CircRNA and lncRNA-associated competing endogenous RNA networks in medulloblastoma: a scoping review.

Nejadi Orang F, Shadbad M Cancer Cell Int. 2024; 24(1):248.

PMID: 39010056 PMC: 11251335. DOI: 10.1186/s12935-024-03427-w.


Cdc14B/Cyclin B1 signaling modulates the pathogenesis of sonic hedgehog subtype medulloblastoma.

Wang T, Wang S, Wang T, Jia L, Nan G, Wang L Am J Cancer Res. 2024; 14(6):2868-2880.

PMID: 39005661 PMC: 11236779. DOI: 10.62347/CVAY8707.


Study of lncRNAs in Pediatric Neurological Diseases: Methods, Analysis of the State-of-Art and Possible Therapeutic Implications.

Pandini C, Rey F, Cereda C, Carelli S, Gandellini P Pharmaceuticals (Basel). 2023; 16(11).

PMID: 38004481 PMC: 10675345. DOI: 10.3390/ph16111616.


The long non-coding RNA OTX2-AS1 promotes tumor growth and predicts response to BCL-2 inhibition in medulloblastoma.

Qin N, Paisana E, Picard D, Leprivier G, Langini M, Custodia C J Neurooncol. 2023; 165(2):329-342.

PMID: 37976029 PMC: 10689561. DOI: 10.1007/s11060-023-04508-y.


The Role of the Dysregulation of Long Non-Coding and Circular RNA Expression in Medulloblastoma: A Systematic Review.

Martinez de Estibariz I, Jakjimovska A, Illarregi U, Martin-Guerrero I, Gutierrez-Camino A, Lopez-Lopez E Cancers (Basel). 2023; 15(19).

PMID: 37835380 PMC: 10571996. DOI: 10.3390/cancers15194686.